ing material (pAPLac, 1) for the synthesis of RhoLac was
synthesized from lactose monohydrate through the 4-steps
chemical modification as reported in the literature (ref. 26).
(200 mL), sodium azide (1.1 g) was added and the resultant
mixture was stirred at 70 °C for 15 h. The mixture was then
diluted with ethyl acetate and washed with aqueous NaCl
solution. The organic layer was dried over anhydrous MgSO4,
filtered, concentrated to dryness and purified through chroma-
tography using a glass column packed with silica gel (40 cm
long; 3 cm i.d.; tolueneethyl acetate = 2:11:1 in v/v) to give
1
13
General.
H and C NMR spectra were acquired on an
AL300 (JEOL RESONANCE) in CDCl . The chemical shifts
3
are reported in ppm (¤) relative to Me Si. IR spectra were
4
recorded on a FT/IR-4100 Fourier transform infrared spec-
trometer (JASCO). Matrix-assisted laser desorption ionization
time-of-flight (MALDI-TOF) mass spectra were recorded on an
AXIMA-CFR+ (SHIMADZU). High-resolution LC-MS and
LC-MS/MS spectra by ESI were recorded on a SYNAPT G2
HDMS (Waters, Co.). UVvis spectra were acquired on a V-
the desired product as marmalade powders (87%, 2 steps).
1
H NMR (300 MHz, CDCl , r.t.): ¤ 7.96 (s, 1H), 7.46 (d, J =
3
8.7 Hz, 2H), 6.96 (d, J = 9.3 Hz, 2H), 5.36 (d, J = 3.3 Hz, 1H),
5.28 (t, J = 7.7 Hz, 1H), 5.16 (t, J = 8.3 Hz, 1H), 5.13 (dd, J =
7.5 and 11.4 Hz, 1H), 5.01 (d, J = 7.8 Hz, 1H), 4.97 (dd, J =
3.3 and 10.2 Hz, 1H), 4.51 (d, J = 7.5 Hz, 1H), 4.514.48 (m,
1H), 4.184.05 (m, 5H), 3.923.86 (m, 2H), 3.793.75 (m, 1H),
2.16 (s, 3H), 2.10 (s, 3H), 2.08 (s, 3H), 2.07 (s, 3H), 2.07 (s,
6
1
30 (JASCO). Lyophilizations were carried out using a FDU-
200 (TOKYO RIKAKIKAI). HPLC analyses were carried out
on our integrated HPLC system (JASCO, pump: PU-2089,
detector: UV-2095, MD-2018, and FP-2020) equipped with
Inertsil ODS-4 (5 ¯m, 4.6 © 250 mm). The FIDAPo measure-
ments were conducted on an MF20 (Olympus). Molecular
dynamics calculation was carried out by using Discovery
Studio 4.0 program (Accelrys, CHARMm, 10 ps equilibrium,
1
3
3H), 2.06 (s, 3H), 1.97 (s, 3H); C NMR (75 MHz, CDCl3,
r.t.): ¤ 170.255, 170.223, 170.042, 169.943, 169.680, 169.499,
169.047, 164.764, 153.609, 132.251, 121.499, 117.380,
100.881, 98.842, 75.981, 72.610, 72.528, 71.196, 70.744,
70.497, 68.894, 66.478, 61.816, 60.682, 52.609, 20.623,
¹
1
1
000 ps dynamics, 300 K).
20.507, 20.458, 20.351; IR (KBr, cm ): 2113, 1753, 1695,
FIDAPo Measurements. We prepared three sample solu-
1608, 1534, 1225; MALDI-TOF-MS (positive mode): m/z
833.11 [M + Na] .
p-2¤¤-Aminoacetamidophenyl-2,3,6,2¤,3¤,4¤,6¤-hepta-O-
+
tions for each condition (oligosaccharide/cation), put them into
three separate wells, and carried out the FIDAPo measurements
on each well ten times (n = 30). Some of the data, however,
largely deviated from the normal distributions, possibly suf-
fering from light scattering arising from small dust particles
and/or bubbles attached onto the glass bottoms. We therefore
removed some data within the highest and the lowest one-third
from the whole data sets to obtain reliable mP values. The mP
values in Table 1 are, therefore, the mean mP values obtained
from the data sets within the middle one-third (n = 10).
p-2¤¤-Chloroacetamidophenyl-2,3,6,2¤,3¤,4¤,6¤-hepta-O-
acetyl-β-lactoside (4).
To p-2¤¤-azidoacetamidophenyl-
2,3,6,2¤,3¤,4¤,6¤-hepta-O-acetyl-β-lactoside (3, 0.41 g) in THF
(40 mL), Pd/C (5%, 0.13 g), acetic acid (0.3 mL), and methanol
(1.0 mL) were added carefully. The resultant mixture was
vigorously stirred under hydrogen atmosphere at the ambient
temperature for overnight until complete consumption of the
substrate was confirmed through TLC analyses (tolueneethyl
acetate = 1:1 v/v). We then removed Pd/C through filtration
and the resultant filtrate was evaporated, dried in vacuo, re-
dissolved into water, and lyophilized to give the desired
product in its acetate salt form as pale yellow powders without
any purification processes (94%). The acetic acid was essential
to eliminate side reactions (e.g. migrations of the acetyl groups
from the hydroxy groups to the highly reactive primary amino
acetyl-β-lactoside (2).
To p-aminophenyl-2,3,6,2¤,3¤,4¤,6¤-
hepta-O-acetyl-β-lactoside (1, 0.75 g) in anhydrous THF (70
mL), chloroacetyl chloride (1.5 mL) and triethylamine (2.8 mL)
were added, and the resultant mixture was stirred at room
temperature for 30 min. The mixture was then poured into iced
water, diluted with ethyl acetate, and washed repeatedly with
1
group) in this reaction. H NMR (300 MHz, CDCl3 + CD3OD,
NaHCO saturated aqueous solution. The organic layer was
r.t.): ¤ 7.54 (br s, 2H), 6.96 (br s, 2H), 5.36 (d, J = 2.7 Hz, 1H),
5.28 (t, J = 9.6 Hz, 1H), 5.16 (t, J = 8.4 Hz, 1H), 5.12 (dd,
J = 7.8 and 10.2 Hz, 1H), 5.03 (d, J = 7.5 Hz, 1H), 4.97 (dd,
J = 3.0 and 10.5 Hz, 1H), 4.554.48 (m, 2H), 4.194.07 (m,
3H), 3.963.37 (m, 2H), 3.833.76 (m, 1H), 3.43 (s, 2H), 2.17
(s, 3H), 2.11 (s, 3H), 2.08 (s, 9H), 2.07 (s, 3H), 1.98 (s, 3H);
3
dried over anhydrous MgSO , filtered, and concentrated to
4
dryness to give the desired product as pale yellow powders.
1
H NMR (300 MHz, CDCl , r.t.): ¤ 8.19 (s, 1H), 7.46 (d, J =
3
9.0 Hz, 2H), 6.98 (d, J = 9.0 Hz, 2H), 5.36 (d, J = 2.7 Hz, 1H),
5.28 (t, J = 9.0 Hz, 1H), 5.16 (dd, J = 7.5 and 9.0 Hz, 1H),
5.13 (dd, J = 7.5 and 10.5 Hz, 1H), 4.97 (dd, J = 3.3 and
10.2 Hz, 1H), 4.524.48 (m, 2H), 4.19 (s, 2H), 4.174.14 (m,
1H), 4.134.08 (m, 2H), 3.923.86 (m, 2H), 3.803.75 (m, 1H),
2.16 (s, 3H), 2.10 (s, 3H), 2.08 (s, 3H), 2.07 (s, 3H), 2.07 (s,
3
H), 2.06 (s, 3H), 1.97 (s, 3H); 13C NMR (75 MHz, CDCl3,
1
3
C NMR (75 MHz, CDCl , r.t.): ¤ 170.338, 170.124, 170.042,
3
169.738, 169.581, 169.088, 151.422, 135.679, 125.445,
117.528, 101.021, 98.999, 76.104, 72.676, 71.352, 70.859,
70.621, 68.985, 66.535, 61.915, 60.748, 30.224, 21.108,
¹1
20.738, 20.581, 20.458; IR (KBr, cm ): 2959, 1752, 1509,
+
r.t.): ¤ 170.798, 170.741, 170.576, 170.494, 170.190, 170.034,
1227; ESI-MS (positive mode): obs. m/z 785.2593 [M + H]
1
1
7
2
69.540, 164.238, 154.480, 132.465, 122.189, 118.062,
01.522, 99.451, 76.573, 73.218, 73.144, 71.829, 71.328,
1.130, 69.462, 66.987, 62.384, 61.208, 43.205, 21.206,
(calc. 785.2617 for C H N O ).
3
4
45
2
19
RhoLac (6).
To p-2¤¤-aminoacetamidephenyl-
2,3,6,2¤,3¤,4¤,6¤-hepta-O-acetyl-β-lactoside (4, 15 mg) in DMF
(1 mL), NaHCO3 (15 mg) and RhoNHS (4.8 mg) were added,
and the resultant mixture was incubated at the ambient temper-
ature for overnight. After the successful coupling to access 5
was confirmed through TLC (chloroform/methanol = 9/1 v/v)
¹
1
1.058, 20.927; IR (KBr, cm ): 1753, 1684, 1540, 1227;
+
MALDI-TOF-MS (positive mode): m/z 826.10 [M + Na] .
p-2¤¤-Azidoacetamidophenyl-2,3,6,2¤,3¤,4¤,6¤-hepta-O-acet-
yl-β-lactoside (3).
To p-2¤¤-chloroacetamidophenyl-
+
2
,3,6,2¤,3¤,4¤,6¤-hepta-O-acetyl-β-lactoside (2, 0.75 g) in DMF
and MALDI-TOF-MS ([M + H] = 1197.03, calc. 1197.40)
© 2016 The Chemical Society of Japan | 623